Alfredo Giacchetti

CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome

Wnt signaling in cancer

WNT signalling pathways as therapeutic targets in cancer

WHO-EORTC classification for cutaneous lymphomas

Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017

Treatment of Cutaneous T Cell Lymphoma

Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine

Progress and problems in the application of focused ultrasound for blood–brain barrier disruption

β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient Melanomas

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

Occupational allergic contact dermatitis from 2‐hydroxyethyl methacrylate and ethylene glycol dimethacrylate in a modified acrylic structural adhesive

Mycosis fungoides and the Sézary syndrome

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

Romidepsin: A Histone Deacetylase Inhibitor for Refractory Cutaneous T-Cell Lymphoma

Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome

Nanotechnology for Multimodal Synergistic Cancer Therapy

A Review of Glass-Ionomer Cements for Clinical Dentistry

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

Natural product and natural product derived drugs in clinical trials

CutaneousT‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management

How I treat mycosis fungoides and Sézary syndrome

Long‐term experience with low‐dose interferon‐α and PUVA in the management of early mycosis fungoides

Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas

Involvement of E-cadherin, β-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma

Low dose interferon-alpha2b combined with PUVA is an effective treatment of early stage mycosis fungoides: results of a multicenter study. Cutaneous-T Cell Lymphoma Multicenter Study Group.

Unusual sensitization to cyanoacrylate ester